TURNOVER (x1000 DKK)
NET PROFIT (x1000 DKK)
Biobank AS
Closing information (x1000 DKK)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
9,236
|
10,270
|
9,634 |
Financial expenses |
19
|
22
|
25 |
Earnings before taxes |
1,281
|
262
|
695 |
Total assets |
9,887
|
10,229
|
11,110 |
Current assets |
8,653
|
8,535
|
9,082 |
Current liabilities |
1,458
|
1,763
|
1,949 |
Equity capital |
6,782
|
6,161
|
6,279 |
- share capital |
199
|
212
|
224 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
68.6%
|
60.2%
|
56.5% |
Turnover per employee | |||
Profit as a percentage of turnover |
13.9%
|
2.6%
|
7.2% |
Return on assets (ROA) |
13.1%
|
2.8%
|
6.5% |
Current ratio |
593.5%
|
484.1%
|
466.0% |
Return on equity (ROE) |
18.9%
|
4.3%
|
11.1% |
Change turnover |
-402
|
1,142
|
-1,068 |
Change turnover % |
-4%
|
13%
|
-10% |
Chg. No. of employees | |||
Chg. No. of employees % |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.